Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHerald Regulatory News (HRI)

Share Price Information for Herald (HRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,190.00
Bid: 2,185.00
Ask: 2,195.00
Change: -10.00 (-0.45%)
Spread: 10.00 (0.458%)
Open: 2,185.00
High: 2,205.00
Low: 2,185.00
Prev. Close: 2,200.00
HRI Live PriceLast checked at -
Herald is an Investment Trust

To achieve capital appreciation through investments in smaller quoted companies in the areas of telecommunications, multimedia and technology.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Chairman’s AGM Statement

17 Apr 2020 15:35

RNS Number : 0917K
Herald Investment Trust PLC
17 April 2020
 

HERALD INVESTMENT TRUST PLC

Chairman's AGM Statement

During 2019, the Company's net asset value per share ("NAV") appreciated by 27.5%. It rose further during 2020 until 20th February when the market was adversely affected by the coronavirus pandemic. Covid-19 is clearly having a widespread adverse, but as yet unquantifiable, impact on corporate profitability. However, of the approximately 300 holdings in the Company, to date only a modest number have been materially affected and many investee companies are experiencing increased demand. With a significant proportion of the population in the developed world now in lockdown, many people are using technology at home to work, for communication, for shopping and leisure. It is evident how much the internet and cloud computing are alleviating the challenges of social distancing, thus mitigating the effects on people's wellbeing and on the economy.

Technology is also enabling the Manager to access all necessary systems to administer the Company from remote locations, but communication within the team is more challenging. Furthermore, the numerous conference calls with investee companies are an inferior substitute to the live meetings that would have occurred in more normal times.

However, the technology sector on which the Company is focused is clearly better placed than many other sectors. This is reflected in a quantifiable correction in the net asset value per share which is usefully less than the wider indices. Overall year to date, the "NAV" has declined 12.3%. The regional returns in £ are as follows:

Herald UK portfolio -18.6%

Numis Smaller Companies Index -26.6%(Ex Investment companies inc AIM)

 

Herald North America portfolio -6.0%

Russell 2000 Technology Index -14.0%

 

Herald EMEA portfolio -15.5%

Herald Asia portfolio -6.1%

 

Herald "NAV" 31/12/2019 to 15/04/2020 -12.3%

The overall decline has also been mitigated by the weakness of the £ relative to the US$ and the high levels of cash and US Treasuries in the portfolio.

Cash and cash equivalents are only some £10m below peak levels at £125m. The Manager has not yet aggressively purchased stock in the belief that there will be a stream of follow on fund raisings for investee companies which have already started to occur, and that good buying opportunities will occur in coming months.

Please select the link below for a slide presentation from the Investment Manager:

 

http://www.rns-pdf.londonstockexchange.com/rns/0917K_1-2020-4-17.pdf

 

Ian Russell

Chairman

17th April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMZDLFFBZLLBBQ
Date   Source Headline
14th Dec 20221:39 pmRNSNet Asset Value(s)
13th Dec 20222:07 pmRNSNet Asset Value(s)
12th Dec 202212:25 pmRNSNet Asset Value(s)
9th Dec 20221:14 pmRNSNet Asset Value(s)
9th Dec 20227:00 amRNSStatistics and Performance Report
8th Dec 20221:36 pmRNSNet Asset Value(s)
7th Dec 20221:23 pmRNSNet Asset Value(s)
7th Dec 20227:00 amRNSTransaction in Own Shares
6th Dec 202212:39 pmRNSNet Asset Value(s)
5th Dec 20221:16 pmRNSNet Asset Value(s)
2nd Dec 202212:56 pmRNSNet Asset Value(s)
1st Dec 20222:39 pmRNSNet Asset Value(s)
1st Dec 20227:00 amRNSTotal Voting Rights
30th Nov 20221:15 pmRNSNet Asset Value(s)
30th Nov 20227:00 amRNSTransaction in Own Shares
29th Nov 20223:49 pmRNSNet Asset Value(s)
28th Nov 20221:56 pmRNSNet Asset Value(s)
25th Nov 20221:28 pmRNSNet Asset Value(s)
24th Nov 20221:49 pmRNSNet Asset Value(s)
23rd Nov 20221:04 pmRNSNet Asset Value(s)
22nd Nov 20222:19 pmRNSNet Asset Value(s)
21st Nov 20221:04 pmRNSNet Asset Value(s)
18th Nov 20221:25 pmRNSNet Asset Value(s)
17th Nov 20221:19 pmRNSNet Asset Value(s)
16th Nov 20221:11 pmRNSNet Asset Value(s)
15th Nov 20221:09 pmRNSNet Asset Value(s)
14th Nov 20223:52 pmRNSStatistics and Performance Report
14th Nov 20221:11 pmRNSNet Asset Value(s)
11th Nov 20221:30 pmRNSNet Asset Value(s)
10th Nov 20225:41 pmRNSDirector/PDMR Shareholding Replacement
10th Nov 20223:12 pmRNSDirector/PDMR Shareholding
10th Nov 20221:03 pmRNSNet Asset Value(s)
9th Nov 20221:44 pmRNSNet Asset Value(s)
8th Nov 202212:56 pmRNSNet Asset Value(s)
7th Nov 20222:29 pmRNSNet Asset Value(s)
4th Nov 202212:51 pmRNSNet Asset Value(s)
3rd Nov 20221:23 pmRNSNet Asset Value(s)
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20221:24 pmRNSNet Asset Value(s)
1st Nov 20222:01 pmRNSNet Asset Value(s)
1st Nov 20227:00 amRNSTotal Voting Rights
31st Oct 202212:09 pmRNSNet Asset Value(s)
28th Oct 20221:08 pmRNSNet Asset Value(s)
27th Oct 20221:20 pmRNSNet Asset Value(s)
26th Oct 20221:08 pmRNSNet Asset Value(s)
25th Oct 20221:23 pmRNSNet Asset Value(s)
24th Oct 20221:24 pmRNSNet Asset Value(s)
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 202212:43 pmRNSNet Asset Value(s)
20th Oct 202212:57 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.